Assessing Psychosocial Risk in Pediatric Inflammatory Bowel Disease: Validation of the Psychosocial Assessment Tool 2.0_General
Overview
Affiliations
Aim: The aim of this study was to present the preliminary psychometric properties of the Psychosocial Assessment Tool 2.0_General (PAT2.0_GEN), a brief screener for psychosocial risk in families of children with inflammatory bowel disease (IBD).
Methods: Caregivers of 42 youth with IBD were recruited and administered a battery of measures including the PAT2.0_GEN and well-validated measures of child emotional and behavioral functioning at baseline and at a 6-month follow-up.
Results: Internal consistency for the PAT2.0_GEN total score was good (α=0.82). Baseline was significantly associated with the 6-month follow-up (r=0.79, P<0.001). Significant correlations between the baseline PAT2.0 _GEN total score and caregiver-reported Child Behavior Checklist total scores at baseline (r=0.74, P<0.001) and at a 6-month follow-up (r=0.62, P<0.001) support the content and predictive validity of the PAT2.0_GEN. Baseline PAT2.0_GEN was also significantly correlated with youth-reported Child Behavior Checklist total scores at baseline (r=0.37, P=0.02) but not at the 6-month follow-up (r=0.23, P=0.17).
Conclusions: A number of indicators support the concurrent and predictive utility of the PAT2.0_GEN. The PAT2.0_GEN is a promising tool for screening psychosocial risk that could facilitate the provision of psychosocial services to those patients most in need.
Pitch N, Verma R, Davidson L, Robertson T, Anagnostopoulos G, Sunkonkit K BMJ Open. 2023; 13(4):e068867.
PMID: 37185638 PMC: 10151246. DOI: 10.1136/bmjopen-2022-068867.
Cesa K, Cunningham C, Noll R, Kim S Crohns Colitis 360. 2022; 4(2):otac019.
PMID: 35783219 PMC: 9237933. DOI: 10.1093/crocol/otac019.
Verma R, Mehdian Y, Sheth N, Netten K, Vinette J, Edwards A BMJ Paediatr Open. 2020; 4(1):e000671.
PMID: 32789196 PMC: 7389766. DOI: 10.1136/bmjpo-2020-000671.
Colliva C, Cellini M, Dalla Porta F, Ferrari M, Bergamini B, Guerra A PLoS One. 2020; 15(3):e0230194.
PMID: 32203535 PMC: 7089558. DOI: 10.1371/journal.pone.0230194.
Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool.
Reader S, Keeler C, Chen F, Ruppe N, Rash-Ellis D, Wadman J J Pediatr Psychol. 2020; 45(4):423-433.
PMID: 32142136 PMC: 7182400. DOI: 10.1093/jpepsy/jsaa002.